This research received no external funding
Remedy Meds is a telehealth company that focuses solely on compounded GLP-1 weight loss medications
Patients with pre-existing bowel disorders or diabetic gastroparesis, those taking concurrent medications that slow gut motility (such as opioids, tricyclic antidepressants, calcium channel blockers, iron supplements, or antipsychotics), and older adults may be at increased risk
PlexusDx also offers oral semaglutide ($289/mo), tirzepatide injection ($289/mo), and dual-compound GLP-Squared formulations for patients seeking enhanced metabolic support or those with specific genetic markers favoring combination peptide therapy
There was a decrease seen in mean body mass index, from 43.1 to 41.5 kg/m 2
Daily injection would cause rapid accumulation to dangerous levels